tiprankstipranks
Trending News
More News >
Mani, Inc. (JP:7730)
:7730
Japanese Market

Mani, Inc. (7730) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Mani, Inc.

(7730)

Rating:76Outperform
Price Target:
¥1,363.00
▲(13.68%Upside)
Mani, Inc. is a financially strong company with robust revenue growth and profitability margins. The technical analysis supports a neutral stance with balanced momentum, while the valuation metrics are reasonable. The absence of earnings call and corporate events data limits additional insights.

Mani, Inc. (7730) vs. iShares MSCI Japan ETF (EWJ)

Mani, Inc. Business Overview & Revenue Model

Company DescriptionMani, Inc. engages in the research, development, manufacture, and distribution of medical devices and dental instruments in Japan and internationally. The company offers surgical instruments, such as maniplers, vessel knives, knives, stainless wire needles, and saws used in surgical operations for incision, cutting, and suture; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for eye surgeries, including cataract operations. It also provides surgical eyeless and eyed needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. In addition, the company imports and sells medical devices. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.
How the Company Makes MoneyMani, Inc. generates revenue through the sale of its medical, dental, and surgical instruments worldwide. The company earns a substantial portion of its income from the dental segment, which involves selling specialized tools and instruments to dental professionals and clinics. Additionally, its surgical products division contributes significantly to its earnings by providing hospitals and medical institutions with high-quality surgical sutures and needles. Mani, Inc. also benefits from its global distribution network and partnerships with healthcare providers, ensuring a consistent demand for its products across various international markets.

Mani, Inc. Financial Statement Overview

Summary
Mani, Inc. demonstrates strong financial performance with consistent revenue growth and robust profitability margins. The company maintains a stable balance sheet with low leverage and high equity ratio, though there are concerns regarding free cash flow stability due to significant capital expenditures.
Income Statement
90
Very Positive
Mani, Inc. demonstrates strong financial performance with a consistent increase in revenue from 2020 to 2024. The gross profit margin has remained robust, reflecting efficient cost management. Net profit margin has improved, indicating enhanced profitability. Notably, the EBIT and EBITDA margins have shown positive trends, underscoring operational efficiency.
Balance Sheet
85
Very Positive
The balance sheet of Mani, Inc. reflects financial stability with a low debt-to-equity ratio, indicating conservative leverage. The return on equity is strong, showcasing effective use of shareholders' equity to generate profits. A high equity ratio further illustrates the company's solid financial foundation.
Cash Flow
75
Positive
Mani, Inc. displays a mixed cash flow performance. While operating cash flow is healthy, free cash flow has shown volatility due to significant capital expenditures in recent years. The free cash flow to net income ratio is low, suggesting potential constraints in cash availability for strategic investments.
Breakdown
TTMSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income StatementTotal Revenue
29.05B28.51B24.49B20.42B17.19B15.20B
Gross Profit
18.45B17.90B15.42B12.57B11.01B9.88B
EBIT
8.28B8.39B7.24B6.16B5.35B4.34B
EBITDA
10.47B10.70B9.94B9.17B7.55B6.26B
Net Income Common Stockholders
6.31B6.29B5.95B5.29B4.29B3.33B
Balance SheetCash, Cash Equivalents and Short-Term Investments
6.29B21.66B25.43B22.73B18.89B17.18B
Total Assets
32.49B57.18B54.98B50.11B42.69B39.29B
Total Debt
0.0083.00M58.00M117.00M128.00M62.48M
Net Debt
-6.29B-21.56B-25.37B-22.61B-18.16B-17.11B
Total Liabilities
3.27B4.85B5.15B4.70B3.49B2.72B
Stockholders Equity
29.22B52.33B49.83B45.41B39.20B36.57B
Cash FlowFree Cash Flow
0.00129.00M4.31B4.62B2.52B248.97M
Operating Cash Flow
0.007.81B8.03B6.56B6.38B1.94B
Investing Cash Flow
0.00-6.64B-4.02B-2.17B-3.44B-38.33M
Financing Cash Flow
0.00-3.70B-3.25B-2.44B-2.23B-2.13B

Mani, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1199.00
Price Trends
50DMA
1192.02
Positive
100DMA
1296.53
Negative
200DMA
1548.40
Negative
Market Momentum
MACD
1.36
Positive
RSI
49.63
Neutral
STOCH
17.53
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7730, the sentiment is Negative. The current price of 1199 is below the 20-day moving average (MA) of 1205.32, above the 50-day MA of 1192.02, and below the 200-day MA of 1548.40, indicating a neutral trend. The MACD of 1.36 indicates Positive momentum. The RSI at 49.63 is Neutral, neither overbought nor oversold. The STOCH value of 17.53 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7730.

Mani, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥118.12B19.57
3.25%11.54%-8.30%
54
Neutral
$5.31B3.26-45.10%2.79%16.76%0.02%
$4.37B63.237.09%0.80%
DE5FR
€472.44M13.386.62%2.88%
DE6SN
€981.22M28.574.78%2.74%
$962.11M17.106.55%3.60%
61
Neutral
¥72.83B16.80
2.40%15.55%42.14%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7730
Mani, Inc.
1,191.00
-685.87
-36.54%
AHICF
Asahi Intecc Co
16.15
1.67
11.53%
DE:5FR
Menicon Co
6.05
-1.14
-15.86%
DE:6SN
Nakanishi
11.30
-2.21
-16.36%
PBHDF
Paramount Bed Holdings Co
17.85
0.02
0.11%
JP:7979
Shofu Inc.
2,044.00
68.36
3.46%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.